Investing in the Future of Precision Cancer Medicine

Developing a first-in-class, 3rd generation Polo-like Kinase 1 (PLK1) Inhibitor to treat leukemias, lymphomas
and solid tumor cancers

2017 Southern California Investor Conference
August 24, 2017
11:00am - 11:30am PDT
Venue
The Island Hotel
located adjacent to the Fashion Island Mall at 690 Newport Center Drive

Bill Welch, CEO of Trovagene will be presenting an overview of the Company on Thursday, August 24th, at 11:00 am PDT.